Metraipolis › archive › dc_50f4da2ee1fc

Abiraterone acetate — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Abiraterone_acetate
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T07:28:19.761Z
SHA-256 of the archived text
98b6b309275e0e93acd63af8cbe74bef8e51d7ffe4806dea38df29bfc5e1f47c
Stable URL of this page
https://metraipolis.com/documento/dc_50f4da2ee1fc

How to cite

Abiraterone acetate — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Abiraterone_acetate (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_50f4da2ee1fc (Metraipolis archive dc_50f4da2ee1fc, sha256 98b6b309275e0e93acd63af8cbe74bef8e51d7ffe4806dea38df29bfc5e1f47c)
BibTeX
@misc{dc50f4da2ee1fc,
  title = {Abiraterone acetate — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Abiraterone_acetate},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_50f4da2ee1fc; sha256 98b6b309275e0e93acd63af8cbe74bef8e51d7ffe4806dea38df29bfc5e1f47c},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Abiraterone_acetate. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog. It is taken by mouth. Common side effects include tiredness, vomiting, headache, joint pain, high blood pressure, swelling, low blood potassium, high blood sugar, hot flashes, diarrhea, and cough. Other severe side effects may include liver failure and adrenocortical insufficiency. In males whose partners can become pregnant, birth control is recommended. Supplied as abiraterone acetate it is converted in the body to abiraterone. Abiraterone acetate works by suppressing the production of androgens – specifically it inhibits CYP17A1 – and thereby decreases the production of testosterone. In doing so, it prevents the effects of these hormones in prostate cancer. Abiraterone acetate was described in 1995, and approved for medical use in the United States and the European Union in 2011. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Abiraterone acetate» — https://en.wikipedia.org/wiki/Abiraterone_acetate
Wikidata Q27888393: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q27888393
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Abiraterone_acetate?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1354022007, consultata il 2026-11-07T07:23:55.487Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: d0d30a3eb5e893799a0b6eead96422cb61ff3fe1f557c509510c126a7ff1ca09